Sinoway Industrial Co., Ltd.

Pitavastatin vápník 147526-32-7 Pitavastatin vápník 147526-32-7

Pitavastatin vápník 147526-32-7
Související produkty
  • L-Glutathion Reduced (GSH) 70-18-8

    L-Glutathion Reduced Základní informace o L-Glutathion Reduced: Název produktu: Redukovaný L-Glutathion Formula: C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc ...

  • Copper Peptide (GHK) 2-CU 49557-75-7

    Měď peptid GHK-CuBasické informace o mědi peptid GHK-Cu: Název produktu (GHK) 2-Cu (měďnatý peptid) SynonymaGHK-Cu (měděný peptid) CAS # 49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2 ...

  • Isoflavony v sóji 574-12-9

    Sójový extrakt1.Základní informace o sójovém extraktu: Název produktu: Sójový extraktSource: glycine maxUsed část: zárodečná buničinaSpec .: celková sója isoflavon 40%, 80% HPLCNameSoybean Extract PowderTyp ...

Základní informace o Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Použití pitavastatinu vápníku 147526-32-7

  • Pitavastatin vápník je indikován pro hypercholesterolemii (zvýšený cholesterol) a pro prevenci kardiovaskulárních onemocnění.

COA z pitavastatinu vápníku 147526-32-7

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatin vápník 147526-32-7

Základní informace o Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Použití pitavastatinu vápníku 147526-32-7

  • Pitavastatin vápník je indikován pro hypercholesterolemii (zvýšený cholesterol) a pro prevenci kardiovaskulárních onemocnění.

COA z pitavastatinu vápníku 147526-32-7

Pitavastatin Calcium 147526-32-7
Související články
Zanechat zprávu Pošlete nám e-mail

Budeme vás kontaktovat do 24 hodin.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Patro 16, Huicheng Business Centre, č. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, Čína